House Hearing on Purdue Pharma and the Opioid Epidemic
Top executives of Purdue Pharma, a U.S. pharmaceutical company that makes OxyContin, testified about their role in the opioid epidemic at a… read more
Top executives of Purdue Pharma, a U.S. pharmaceutical company that makes OxyContin, testified about their role in the opioid epidemic at a virtual House Oversight Committee hearing. The company recently pleaded guilty to criminal charges as part of a settlement with the Justice Department. Witnesses included Purdue Pharma CEO Dr. Craig Landau along with two of the company’s former owners, David and Kathe Sackler. Video testimonials were played from family members of opioid epidemic victims. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
More PeopleHosting Organization
Related Video
-
Justice Department News Conference on Purdue Pharma Settlement
The Justice Department held a news conference announcing the settlement reached with Purdue Pharma over their role in…
-
Pharmaceutical Executives Testimony on Drug Pricing, Day 2
Amgen CEO Robert Bradway, Novartis U.S. Country President Thomas Kendris, and Mallinckrodt Pharmaceuticals CEO Mark…
-
Pharmaceutical Executives Testimony on Drug Pricing, Day 1
Bristol-Myers Squibb CEO Dr. Giovanni Caforio, Teva CEO Kare Schultz and former Celgene CEO Mark Alles testified on…
-
House Oversight and Reform Committee Hearing on Prescription Drug Prices
The House Oversight and Reform Committee held a hearing on prescription drug prices and their impact on patients. Four…